Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
Dihexa consists of two hydrophobic amino acids Tyr-Ile with the full sequence as follows: Hexanoyl-Tyr-Ile-Ahx-NH 2
The consistent findings across different modelsfrom improved cell viability and reduced apoptosis to the downregulation of inflammatory markersunderscore its potential as a therapeutic agent
Ingredients L-Glutathione (reduced form) Directions Take 2 capsules per day, preferebly on an empty stomach or as directed by a healthcare professional
In hospital, the patient received complex symptomatic therapy
